Further experiments suggested that SETD1A promoted Wnt/β-catenin pathway activity and the malignant behaviors in NSCLC cells, at least, partly by upregulating NEAT1 and EZH2 expression. The gene discussed is SETD1A; the disease is non-small cell lung carcinoma.